Genesis Energy LP (GEL) to pay $0.55 on May 15, 2019; Profile of 3 Analysts Covering Croda International Plc (LON:CRDA) – The FinExaminer

Genesis Energy LP (GEL) to pay $0.55 on May 15, 2019; Profile of 3 Analysts Covering Croda International Plc (LON:CRDA)  The FinExaminer

Genesis Energy LP (NYSE:GEL) is expected to pay $0.55 on May 15, 2019. (NYSE:GEL) shareholders before Apr 30, 2019 will receive the $0.55 dividend.

Genesis Energy, L.P. (NYSE:GEL) Logo

Genesis Energy LP (NYSE:GEL) is expected to pay $0.55 on May 15, 2019. (NYSE:GEL) shareholders before Apr 30, 2019 will receive the $0.55 dividend. Genesis Energy LP’s current price of $23.21 translates into 2.37% yield. Genesis Energy LP’s dividend has May 1, 2019 as record date. Apr 12, 2019 is the announcement. The stock increased 1.80% or $0.41 during the last trading session, reaching $23.21. About 619,425 shares traded or 8.35% up from the average. Genesis Energy, L.P. (NYSE:GEL) has risen 6.47% since April 15, 2018 and is uptrending. It has outperformed by 2.10% the S&P500. Some Historical GEL News: 08/03/2018 – EYEGATE PHARMACEUTICALS – SUBMITTED AMENDED IDE APPLICATION TO U.S. FDA FOR A PILOT STUDY OF EYEGATE OCULAR BANDAGE GEL; 07/05/2018 – MALLINCKRODT: SYNACTHEN TETRACOSACTIDE ISN’T H.P. ACTHAR GEL; 26/04/2018 – ClinicalTrial US: Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea; 08/05/2018 – MALLINCKRODT PLC – QTRLY H.P. ACTHAR GEL NET SALES WERE $243.8 MLN, DOWN 10.3% OVER $271.8 MLN DUE TO RESIDUAL IMPACT OF PATIENT WITHDRAWAL ISSUES; 22/05/2018 – ASICS Launches The 25th lteration Of The GEL-KAYANO® Series, Helping Runners Go The Distance; 22/04/2018 – The 2018 Genesis G80 Sport is a great car with the wrong name; 16/03/2018 – CUMBERLAND – HAS REMOVED OBLIGATION TO PROVIDE GEL WITH ROYALTY PAYMENTS BASED ON GROSS MARGIN AS WELL AS FEES FOR OVERSEEING PRODUCT’S MANUFACTURING; 07/05/2018 – Mallinckrodt: Information on H.P. Acthar Gel Posted on Website in Response to ’60 Minutes’ Report; 18/05/2018 – Genesis Essentia Makes Appearance At Cannes; 22/03/2018 – ClinicalTrial US: Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis

Among 5 analysts covering Croda International PLC (LON:CRDA), 3 have Buy rating, 1 Sell and 1 Hold. Therefore 60% are positive. Croda International PLC had 14 analyst reports since November 1, 2018 according to SRatingsIntel. Barclays Capital maintained Croda International Plc (LON:CRDA) rating on Friday, December 7. Barclays Capital has “Overweight” rating and GBX 5300 target. The stock of Croda International Plc (LON:CRDA) earned “Neutral” rating by Goldman Sachs on Monday, December 10. The firm has “Hold” rating by Liberum Capital given on Thursday, November 1. Deutsche Bank maintained Croda International Plc (LON:CRDA) on Friday, November 2 with “Hold” rating. The firm earned “Buy” rating on Tuesday, January 8 by HSBC. The firm has “Buy” rating by HSBC given on Thursday, December 13. The rating was maintained by Goldman Sachs with “Neutral” on Tuesday, November 27. The firm has “Underperform” rating by Credit Suisse given on Wednesday, January 9. The stock of Croda International Plc (LON:CRDA) has “Neutral” rating given on Monday, February 4 by Goldman Sachs. As per Monday, February 18, the company rating was maintained by Goldman Sachs. See Croda International Plc (LON:CRDA) latest ratings:

28/02/2019 Broker: Deutsche Bank Rating: Hold Old Target: GBX 4800.00 Maintain
28/02/2019 Broker: Liberum Capital Rating: Hold Old Target: GBX 4600.00 Maintain
26/02/2019 Broker: Liberum Capital Rating: Hold Old Target: GBX 4600.00 Maintain
18/02/2019 Broker: Goldman Sachs Rating: Neutral Maintain
04/02/2019 Broker: Goldman Sachs Rating: Neutral Old Target: GBX 4905.00 New Target: GBX 5000.00 Maintain
09/01/2019 Broker: Credit Suisse Rating: Underperform Old Target: GBX 3600.00 New Target: GBX 3900.00 Maintain
08/01/2019 Broker: HSBC Rating: Buy Old Target: GBX 5400.00 Maintain
13/12/2018 Broker: HSBC Rating: Buy Old Target: GBX 5400.00 Maintain
10/12/2018 Broker: Goldman Sachs Rating: Neutral Maintain
07/12/2018 Broker: Barclays Capital Rating: Overweight Old Target: GBX 4850.00 New Target: GBX 5300.00 Maintain

Investors sentiment decreased to 1.4 in 2018 Q4. Its down 0.23, from 1.63 in 2018Q3. It worsened, as 4 investors sold Croda International Plc shares while 16 reduced holdings. 8 funds opened positions while 20 raised stakes. 8.32 million shares or 1.35% less from 8.43 million shares in 2018Q3 were reported. Natl Bank Of Montreal Can owns 157 shares. Parametric Associates Ltd has 0% invested in Croda International Plc (LON:CRDA) for 16,866 shares. Tiaa Cref Investment Limited Com holds 56,861 shares or 0% of its portfolio. Bragg Fincl Advsr has invested 0.04% in Croda International Plc (LON:CRDA). Raymond James And Assocs holds 0% in Croda International Plc (LON:CRDA) or 11,012 shares. Renaissance Technology Limited Liability Corp holds 741,097 shares or 0.01% of its portfolio. State Street Corp stated it has 250,801 shares or 0% of all its holdings. Jpmorgan Chase And owns 0% invested in Croda International Plc (LON:CRDA) for 4,047 shares. Gp accumulated 7,695 shares or 0% of the stock. 47,975 are owned by Ionic Capital Mngmt Lc. Lsv Asset Mngmt holds 0% in Croda International Plc (LON:CRDA) or 293,072 shares. The Massachusetts-based Geode Capital Mgmt Ltd has invested 0% in Croda International Plc (LON:CRDA). Cambridge Inv Rech invested in 0.01% or 71,013 shares. Gsa Partners Limited Liability Partnership reported 25,210 shares. The Pennsylvania-based Vanguard Gru Inc has invested 0% in Croda International Plc (LON:CRDA).

Croda International Plc creates, makes, and sells specialty chemicals in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of 6.57 billion GBP. It offers adhesives; crop protection additives and adjuvants, speciality additives for agricultural films, and seed enhancement and animal health chemicals; lubricant additives, speciality additives for plastics, coatings and polymers, advanced materials, and vehicle cleaning chemicals; and specialty ingredients for skin care, hair care, sun care, self-tanning, color cosmetics, body care, bath and shower, deodorants, anti-perspirants, depilatories, men’s grooming, oral hygiene, and baby care applications. It has a 27.88 P/E ratio. The firm also provides bio based phase change materials for building and construction markets; dietary supplements; electronics comprising phase change materials, advanced materials, and polymer additives; chemistries, emulsifiers, fuel and power generation additives, and polymer additives for energy and resource industries; food additives; speciality polymer additives for furniture and wood applications; household, industrial, and institutional cleaning products; lubricants; oleochemicals; industrial chemicals for packaging, print, and paper industries; paints and coatings; active pharmaceutical ingredients for treating illness and diseases; thermal management products; and plastic and rubber products for food packaging, carrier bags and toys, car bumpers, mobile phones, and home appliances.

Another recent and important Croda International Plc (LON:CRDA) news was published by Seekingalpha.com which published an article titled: “DSM: There Is Still Upside Left After The 40% YTD Run – Seeking Alpha” on April 08, 2019.

The stock decreased 0.44% or GBX 22 during the last trading session, reaching GBX 5030. About 18,572 shares traded. Croda International Plc (LON:CRDA) has 0.00% since April 15, 2018 and is . It has underperformed by 4.37% the S&P500.

More notable recent Genesis Energy, L.P. (NYSE:GEL) news were published by: Seekingalpha.com which released: “Genesis Energy declares common unit distribution of $0.55 – Seeking Alpha” on April 12, 2019, also Seekingalpha.com with their article: “Midstream Lollygags Into Quarter End – Seeking Alpha” published on March 31, 2019, Cnbc.com published: “How PagerDuty’s CEO survived the IPO roadshow: Karaoke, sneakers, oysters and protein shakes – CNBC” on April 13, 2019. More interesting news about Genesis Energy, L.P. (NYSE:GEL) were released by: Seekingalpha.com and their article: “Genesis Energy declares $0.55 dividend – Seeking Alpha” published on January 10, 2019 as well as Benzinga.com‘s news article titled: “Anheuser-Busch Inbev SA (NYSE:BUD), Compass Diversified Holdings (NYSE:CODI) – Hemp Industry Outlook: Startups, Mergers And Acquisitions Abound – Benzinga” with publication date: March 18, 2019.

Among 4 analysts covering Genesis Energy (NYSE:GEL), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Genesis Energy has $29 highest and $23 lowest target. $25.25’s average target is 8.79% above currents $23.21 stock price. Genesis Energy had 6 analyst reports since November 2, 2018 according to SRatingsIntel. The rating was maintained by Barclays Capital on Friday, November 2 with “Equal-Weight”. The firm has “Buy” rating given on Wednesday, February 20 by Raymond James. Barclays Capital maintained the stock with “Hold” rating in Thursday, February 21 report. As per Friday, November 2, the company rating was maintained by Robert W. Baird. The firm has “Outperform” rating by RBC Capital Markets given on Friday, November 2.

Investors sentiment decreased to 0.73 in Q4 2018. Its down 0.19, from 0.92 in 2018Q3. It dropped, as 16 investors sold Genesis Energy, L.P. shares while 40 reduced holdings. 19 funds opened positions while 22 raised stakes. 87.54 million shares or 0.94% more from 86.72 million shares in 2018Q3 were reported. Monetary Mngmt Grp Inc invested in 3,970 shares or 0.03% of the stock. Northern Trust Corporation holds 0% or 192,533 shares. Sumitomo Mitsui Trust Incorporated owns 47,000 shares for 0% of their portfolio. Perella Weinberg Partners Mngmt Limited Partnership accumulated 106,370 shares or 0.12% of the stock. Stephens Ar invested in 0.01% or 18,132 shares. 46,539 were reported by Tortoise Cap Advsrs Ltd Liability Com. Advisory Incorporated reported 2.63 million shares. Sg Americas Secs holds 42,517 shares. Cincinnati Insur Communications invested 0.03% in Genesis Energy, L.P. (NYSE:GEL). invested in 0.02% or 12,000 shares. Royal State Bank Of Canada stated it has 140,095 shares or 0% of all its holdings. The Ohio-based Fort Washington Inv Advsrs Oh has invested 0.02% in Genesis Energy, L.P. (NYSE:GEL). 249,242 were reported by Hightower Advsrs Limited Liability Company. Jnba Fincl Advsr reported 0% of its portfolio in Genesis Energy, L.P. (NYSE:GEL). Credit Suisse Ag invested 0% in Genesis Energy, L.P. (NYSE:GEL).

Genesis Energy, L.P. (NYSE:GEL) Institutional Positions Chart


Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.